(Q67827028)
Statements
A multicentred, two-year, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive (English)
E. von Kesserü
S. Aydinlik
J. J. Etchepareborda
1 December 1991
1 reference
1 reference
1 reference
1 reference
1 reference